Free Trial

Provexis (PXS) Competitors

GBX 0.46 -0.07 (-12.40%)
(As of 05:42 AM ET)

PXS vs. ALK, SHIP, CLCO, TORO, ICON, PAA, GEL, MMP, AAL, and GNK

Should you be buying Provexis stock or one of its competitors? The main competitors of Provexis include Alkemy Capital Investments (ALK), Tufton Oceanic Assets (SHIP), CloudCoCo Group (CLCO), Chenavari Toro Income Fund (TORO), Iconic Labs (ICON), 22532 (PAA.L) (PAA), Greka Engineering & Technology (GEL), Marwyn Management Partners (MMP), Anglo American (AAL), and Greene King (GNK). These companies are all part of the "transportation" industry.

Provexis vs.

Alkemy Capital Investments (LON:ALK) and Provexis (LON:PXS) are both small-cap financial services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, media sentiment, community ranking, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations.

Alkemy Capital Investments has a beta of 1.78, meaning that its stock price is 78% more volatile than the S&P 500. Comparatively, Provexis has a beta of 1.21, meaning that its stock price is 21% more volatile than the S&P 500.

1.5% of Alkemy Capital Investments shares are owned by institutional investors. Comparatively, 7.9% of Provexis shares are owned by institutional investors. 43.7% of Alkemy Capital Investments shares are owned by insiders. Comparatively, 21.6% of Provexis shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Alkemy Capital Investments received 92 more outperform votes than Provexis when rated by MarketBeat users. Likewise, 76.88% of users gave Alkemy Capital Investments an outperform vote while only 64.21% of users gave Provexis an outperform vote.

CompanyUnderperformOutperform
Alkemy Capital InvestmentsOutperform Votes
153
76.88%
Underperform Votes
46
23.12%
ProvexisOutperform Votes
61
64.21%
Underperform Votes
34
35.79%

Provexis has higher revenue and earnings than Alkemy Capital Investments.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alkemy Capital InvestmentsN/AN/A-£1.77M-£0.23-452.17
Provexis£426.17K24.34N/AN/AN/A

Alkemy Capital Investments has a net margin of 0.00% compared to Provexis' net margin of -73.10%. Alkemy Capital Investments' return on equity of 0.00% beat Provexis' return on equity.

Company Net Margins Return on Equity Return on Assets
Alkemy Capital InvestmentsN/A N/A -258.00%
Provexis -73.10%-138.67%-56.14%

In the previous week, Alkemy Capital Investments' average media sentiment score of 0.00 equaled Provexis'average media sentiment score.

Company Overall Sentiment
Alkemy Capital Investments Neutral
Provexis Neutral

Summary

Alkemy Capital Investments beats Provexis on 6 of the 10 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PXS vs. The Competition

MetricProvexisDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£10.37M£1.17B£5.06B£1.39B
Dividend Yield5.06%3.13%4.97%11.73%
P/E Ratio43.75110.0289.021,551.34
Price / Sales24.341,819.041,207.28209,137.85
Price / CashN/A10.4339.1732.93
Price / BookN/A3.116.082.80
Net IncomeN/A£159.31M£119.07M£152.70M
7 Day Performance-10.35%-1.23%-1.84%-0.51%
1 Month Performance-17.30%-3.99%-3.65%7.08%
1 Year Performance-8.20%87.52%31.62%91.78%

Provexis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PXS
Provexis
N/AGBX 0.46
-12.4%
N/A-8.2%£10.37M£426,168.0043.754Gap Down
ALK
Alkemy Capital Investments
N/AGBX 104
+4.0%
N/A-30.9%£9.16MN/A-413.0425,500Gap Up
SHIP
Tufton Oceanic Assets
N/AGBX 1.24
+0.2%
N/A+28.1%£3.63M£39.75M10.3350
CLCO
CloudCoCo Group
N/AGBX 0.25
-9.1%
N/A-71.5%£1.77M£27.31M-115.00125Gap Down
TORO
Chenavari Toro Income Fund
N/AGBX 0.52
flat
N/A+20.4%£1.60MN/A-17.33N/APositive News
ICON
Iconic Labs
N/AGBX 5.25
+144.2%
N/A-6.2%£586,000.00£600,855.00-15.003Gap Up
High Trading Volume
PAA
22532 (PAA.L)
N/AN/AN/AN/A£0.00N/A0.004,100Gap Up
High Trading Volume
GEL
Greka Engineering & Technology
N/AN/AN/AN/A£0.00N/A0.002,110
MMP
Marwyn Management Partners
N/AN/AN/AN/A£0.00N/A0.001,660
AAL
Anglo American
1.3603 of 5 stars
GBX 2,325
-0.6%
GBX 2,715
+16.8%
+4.4%£28.13B£29.44B-2,244.23129,700Positive News
High Trading Volume
GNK
Greene King
N/AGBX 849.20
+0.0%
N/A+0.0%£2.63B£2.22B21.941,010High Trading Volume

Related Companies and Tools


This page (LON:PXS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners